Chris@NNW, Author at NetworkNewsWire

TuesdayMar 19, 2019 5:00 pm

Eyenovia Inc. (NASDAQ: EYEN) Attends 31st Annual ROTH Conference

Eyenovia (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, glaucoma, mydriasis and other eye diseases. For more information, visit the company's website at www.eyenoviabio.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to…

TuesdayMar 19, 2019 5:00 pm

TrovaGene Inc. (NASDAQ: TROV) Attends 31st Annual ROTH Conference

TrovaGene (NASDAQ: TROV) is a clinical-stage oncology therapeutics company using a precision medicine approach to develop drugs that target mitosis (cell division) to treat various types of cancer, including leukemias, lymphomas and solid tumors. Trovagene has intellectual property and proprietary technology that enables the company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics. For more information, visit the company's website at www.trovagene.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial…

TuesdayMar 19, 2019 5:00 pm

TriMas Corp. (NASDAQ: TRS) Attends 31st Annual ROTH Conference

TriMas (NASDAQ: TRS) is a diversified industrial manufacturer of products for customers in the consumer products, aerospace, industrial, petrochemical, refinery and oil & gas end markets with approximately 4,000 dedicated employees in 13 countries. TriMas provides customers with a wide range of innovative and quality product solutions through the company’s market-leading businesses, reported in three segments: Packaging, Aerospace and Specialty Products. The TriMas family of businesses has strong brand names in the markets served and operates under a common set of values and strategic priorities under the TriMas Business Model. For more information, visit the company's website at www.trimascorp.com. About…

TuesdayMar 19, 2019 5:00 pm

Trecora Resources (NYSE: TREC) Attends 31st Annual ROTH Conference

Trecora Resources (NYSE: TREC) owns and operates a facility located in southeast Texas, just north of Beaumont, which specializes in high purity hydrocarbons and other petrochemical manufacturing. TREC also owns and operates a leading manufacturer of specialty polyethylene waxes and provider of custom processing services located in the heart of the Petrochemical complex in Pasadena, Texas. In addition, the company is the original developer and a 33.4% owner of Al Masane Al Kobra Mining Co., a Saudi Arabian joint stock company. For more information, visit the company's website at www.trecora.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content…

TuesdayMar 19, 2019 5:00 pm

Tricida Inc. (NASDAQ: TCDA) Attends 31st Annual ROTH Conference

Tricida (NASDAQ: TCDA) is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida has successfully completed a pivotal phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. The results of this phase 3 trial, along with results from a successful double-blind, randomized, placebo-controlled phase 1/2 trial and an ongoing 40-week extension trial, TRCA-301E, are intended to serve as the basis for the submission of an NDA for TRC101 under the FDA’s Accelerated Approval Program. For more information, visit…

TuesdayMar 19, 2019 5:00 pm

Transcat Inc. (NASDAQ: TRNS) Attends 31st Annual ROTH Conference

Transcat (NASDAQ: TRNS) is a provider of accredited calibration, repair, inspection and laboratory instrument services. The company is focused on providing best-in-class services and products to highly regulated industries, including life science, aerospace and defense, pharmaceutical, medical device manufacturing and biotechnology. Transcat provides permanent and periodic on-site services, mobile calibration services and in-house services through 21 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry. For more information, visit the company's website…

TuesdayMar 19, 2019 5:00 pm

TPI Composites Inc. (NASDAQ: TPIC) Attends 31st Annual ROTH Conference

TPI Composites (NASDAQ: TPIC) is the only independent manufacturer of composite wind blades for the wind energy market with a global manufacturing footprint. TPI delivers high-quality, cost-effective composite solutions through long-term relationships with leading OEMs in the wind and transportation markets. TPI is headquartered in Scottsdale, Arizona, and operates factories throughout the U.S., China, Mexico and Turkey. For more information, visit the company's website at www.tpicomposites.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most…

TuesdayMar 19, 2019 5:00 pm

Tower International Inc. (NYSE: TOWR) Attends 31st Annual ROTH Conference

Tower International (NYSE: TOWR) is a global manufacturer of engineered automotive structural metal components and assemblies primarily serving original equipment manufacturers (“OEMs”). The company offers our automotive customers a broad product portfolio, supplying body-structure stampings, frame and other chassis structures, and complex welded assemblies for small and large cars, crossovers, pickups and sport utility vehicles. For more information, visit the company's website at www.towerinternational.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner…

TuesdayMar 19, 2019 5:00 pm

Torchlight Energy Resources Inc. (NASDAQ: TRCH) Attends 31st Annual ROTH Conference

Torchlight Energy Resources (NASDAQ: TRCH), based in Plano, Texas, is a high growth oil and gas Exploration and Production (E&P) company with a primary focus on acquisition and development of highly profitable domestic oil fields. The company has assets focused in West and Central Texas where targets are established plays such as the Permian Basin. For more information, visit the company's website at www.torchlightenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner…

TuesdayMar 19, 2019 5:00 pm

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Attends 31st Annual ROTH Conference

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Tonix is developing Tonmya, which is in phase 3 development and has been granted Breakthrough Therapy designation by the FDA, as a bedtime treatment for PTSD. Tonix is also developing TNX-102 SL as a bedtime treatment for agitation in Alzheimer’s disease under a separate IND to support a phase 2, potential pivotal, efficacy study and has been designated a Fast Track development program by the FDA for this…